IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.425
EU - Europa 26.267
AS - Asia 15.611
SA - Sud America 2.833
Continente sconosciuto - Info sul continente non disponibili 965
AF - Africa 464
OC - Oceania 39
Totale 77.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.475
RU - Federazione Russa 7.047
IE - Irlanda 5.580
SG - Singapore 4.904
CN - Cina 3.667
DE - Germania 2.960
HK - Hong Kong 2.945
SE - Svezia 2.684
UA - Ucraina 2.216
BR - Brasile 2.134
IT - Italia 2.088
VN - Vietnam 1.841
FI - Finlandia 1.194
FR - Francia 974
GB - Regno Unito 735
IN - India 482
BD - Bangladesh 461
CA - Canada 449
KR - Corea 337
AR - Argentina 262
MX - Messico 205
ID - Indonesia 157
ZA - Sudafrica 142
NL - Olanda 121
EC - Ecuador 114
JP - Giappone 110
PL - Polonia 109
IQ - Iraq 106
BJ - Benin 103
CO - Colombia 99
ES - Italia 97
TR - Turchia 92
AT - Austria 76
VE - Venezuela 74
EU - Europa 70
IR - Iran 70
BE - Belgio 64
CZ - Repubblica Ceca 57
LT - Lituania 57
PK - Pakistan 55
JM - Giamaica 54
PY - Paraguay 50
CR - Costa Rica 45
SA - Arabia Saudita 41
CL - Cile 40
MY - Malesia 38
EG - Egitto 37
PH - Filippine 37
KE - Kenya 33
MA - Marocco 33
DZ - Algeria 31
UZ - Uzbekistan 31
PE - Perù 30
TT - Trinidad e Tobago 30
EE - Estonia 28
AU - Australia 27
MD - Moldavia 27
SY - Repubblica araba siriana 26
HN - Honduras 25
NI - Nicaragua 22
PR - Porto Rico 22
IL - Israele 21
TN - Tunisia 21
RO - Romania 19
BG - Bulgaria 18
TW - Taiwan 18
CH - Svizzera 17
JO - Giordania 17
AE - Emirati Arabi Uniti 16
ET - Etiopia 16
SV - El Salvador 16
DO - Repubblica Dominicana 15
KZ - Kazakistan 15
TH - Thailandia 15
UY - Uruguay 15
DK - Danimarca 14
GT - Guatemala 14
AL - Albania 13
AZ - Azerbaigian 13
NP - Nepal 13
OM - Oman 13
BB - Barbados 11
BO - Bolivia 10
CW - ???statistics.table.value.countryCode.CW??? 10
KG - Kirghizistan 10
LB - Libano 10
NZ - Nuova Zelanda 10
PA - Panama 10
RS - Serbia 10
GR - Grecia 9
HR - Croazia 9
NG - Nigeria 8
PT - Portogallo 8
BH - Bahrain 7
BS - Bahamas 6
CI - Costa d'Avorio 6
CY - Cipro 6
GE - Georgia 6
GP - Guadalupe 6
SK - Slovacchia (Repubblica Slovacca) 6
Totale 76.597
Salva come PNG Salva come JPEG
Città #
Dublin 5.560
Jacksonville 3.950
San Jose 3.101
Hong Kong 2.935
Singapore 2.075
Dearborn 1.873
Council Bluffs 1.773
Ashburn 1.711
Chandler 1.335
Wilmington 1.285
Beijing 1.084
Moscow 948
Princeton 736
Lawrence 733
Lauterbourg 710
Los Angeles 669
Ho Chi Minh City 588
San Mateo 564
Phoenix 421
Buffalo 410
Hanoi 403
Santa Clara 393
Andover 379
Columbus 379
Piemonte 371
Boardman 320
New York 318
Seoul 315
Ann Arbor 301
Houston 250
Dallas 235
São Paulo 212
Woodbridge 205
Novara 181
Orem 162
Philadelphia 149
Hefei 145
Munich 143
Redondo Beach 142
Milan 138
Atlanta 136
Chicago 122
Frankfurt am Main 122
Guangzhou 117
Düsseldorf 115
Toronto 114
Mexico City 113
Helsinki 112
Nanjing 112
Denver 108
Montreal 107
Cotonou 103
Bremen 102
Kunming 98
Brooklyn 96
Norwalk 94
Chennai 93
Tokyo 93
Rome 91
London 90
Warsaw 90
Nuremberg 88
North Bergen 86
Da Nang 80
Grafing 80
St Louis 80
Tianjin 80
Haiphong 74
Johannesburg 74
Turin 71
Rio de Janeiro 68
Hangzhou 67
Seattle 67
Poplar 63
Falkenstein 61
Manchester 58
San Francisco 58
Stockholm 56
Brussels 54
Jinan 54
San Bernardino 54
Amsterdam 53
Brasília 53
Fairfield 53
Boston 50
Shanghai 48
Mumbai 47
Belo Horizonte 46
Las Vegas 46
Curitiba 45
Brno 42
Nanchang 42
Schaumburg 42
Jakarta 41
Vercelli 40
Quito 39
Miami 38
Charlotte 37
Guayaquil 37
Biên Hòa 36
Totale 42.038
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 262
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 247
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers 228
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 211
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 194
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 192
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 192
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 187
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 186
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 185
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 183
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 179
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 170
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 169
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 168
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 166
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 165
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 162
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 157
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 157
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 154
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 154
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 153
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 152
Targeting p53 in chronic lymphocytic leukemia 152
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 151
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 151
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 151
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 151
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 149
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 149
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 149
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 149
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 148
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 148
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 148
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 148
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 147
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 146
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 146
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 146
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 146
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 144
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 143
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 143
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 142
Factor VIII as a potential player in cancer pathophysiology 142
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 141
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 141
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 141
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 141
The clinical implications of gene mutations in chronic lymphocytic leukaemia 140
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 140
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 139
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 139
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 138
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 138
The genetics of nodal marginal zone lymphoma 138
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 137
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 137
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 137
Libro universitario: Letteratura, medicina e scienze sociali. Convergenze tra culture e linguaggi; Chapter- Per un’etica della condivisione dei benefici in tema di sperimentazione dei farmaci 137
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 136
Absence of NOTCH1 gene mutations in MALT lymphomas 136
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 135
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 135
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 133
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 133
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 132
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 132
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo 132
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 132
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 132
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 132
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 131
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 131
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 131
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 131
Biology and treatment of Richter syndrome 131
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 131
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 130
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 130
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 130
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 130
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 130
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 130
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 129
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 129
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 129
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 129
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 129
Atypical chronic myeloid leukemia: Where are we now? 129
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 128
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 127
Chronic lymphocytic leukaemia: a step ahead in the journey toward eradication 127
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 127
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 126
Totale 15.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 404.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 404.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.856 0 0 0 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202627.258 1.029 893 2.116 3.717 1.947 2.021 4.094 4.696 2.289 2.232 1.455 769
2026/20278.295 1.137 2.389 2.473 2.296 0 0 0 0 0 0 0 0
Totale 77.604